2024 2025 2026 2024 Ivermectin reduces COVID-19 risk: real-time meta-analysis of 106 studies. Significantly lower risk is seen for mortality, ventilation, ICU admission, … A second meta-analysis, Song et al. (2024), reported, “There was no significant difference in all-cause mortality rate between [ivermectin] and controls.” And … 2025 2021 2021 Ivermectin treats or prevents certain parasite infections in animals and in humans. These drugs don\’t treat viruses. Taking large doses of this … Ivermectin treats or prevents certain parasite infections in animals and in humans. These drugs don\’t treat viruses. Taking large doses of this … 2022 2025 Conclusions: In non-hospitalized COVID-19 patients, ivermectin did not have effect on clinical, non- clinical or safety outcomes versus controls … 2024 2025 2024 2025 2024 Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses … The result gathered shows that Ivermectin is effective in treating asymptomatic –to- mild patients only with the collected studies. The researchers believe it is completely plausible, urgent, and necessary to evaluate if ivermectin use reduces the risk of admission to an intensive care unit … 2024 Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. Neither drug has been useful to prevent or treat SARS-CoV-2 … The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on … 2024 2024 Conclusions: In non-hospitalized COVID-19 patients, ivermectin did not have effect on clinical, non- clinical or safety outcomes versus controls … The current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive. Until more data is available, WHO recommends that the drug only be …
